Fructose-Rich Diet Is a Risk Factor for Metabolic Syndrome, Proximal Tubule Injury and Urolithiasis in Rats
Abstract
1. Introduction
2. Results
2.1. Assessment of Nutritional and Metabolic Status
2.2. Assessment of Urine
2.3. Analysis of Urinary Electrolytes Excretion as a Percentage of Dietary Intake
2.4. Kidney Histopathology
3. Discussion
3.1. Fructose Induced Metabolic Syndrome and Inflammation
3.2. Fructose Effects on Macro-Mineral Homeostasis
4. Materials and Methods
4.1. Animal Model
4.2. Laboratory Tests
FEx(x) = (U(x) × SCr/UCr × S(x)) × 100
4.3. Histology
4.4. Statistical Analysis
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Gross, L.S.; Li, L.; Ford, E.S.; Liu, S. Increased Consumption of Refined Carbohydrates and the Epidemic of Type 2 Diabetes in the United States: An Ecologic Assessment. Am. J. Clin. Nutr. 2004, 79, 774–779. [Google Scholar] [CrossRef] [Scilit]
- Johnson, R.J.; Sanchez-Lozada, L.G.; Nakagawa, T. The Effect of Fructose on Renal Biology and Disease. J. Am. Soc. Nephrol. JASN 2010, 21, 2036–2039. [Google Scholar] [CrossRef] [Scilit]
- Azaïs-Braesco, V.; Sluik, D.; Maillot, M.; Kok, F.; Moreno, L.A. A Review of Total & Added Sugar Intakes and Dietary Sources in Europe. Nutr. J. 2017, 16, 6. [Google Scholar] [CrossRef] [Scilit]
- Brymora, A.; Flisiński, M.; Johnson, R.J.; Goszka, G.; Stefańska, A.; Manitius, J. Low-Fructose Diet Lowers Blood Pressure and Inflammation in Patients with Chronic Kidney Disease. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.—Eur. Ren. Assoc. 2012, 27, 608–612. [Google Scholar] [CrossRef] [Scilit]
- Van den Berghe, G. Fructose: Metabolism and Short-Term Effects on Carbohydrate and Purine Metabolic Pathways. Prog. Biochem. Pharmacol. 1986, 21, 1–32. [Google Scholar]
- Mäenpää, P.H.; Raivio, K.O.; Kekomäki, M.P. Liver Adenine Nucleotides: Fructose-Induced Depletion and Its Effect on Protein Synthesis. Science 1968, 161, 1253–1254. [Google Scholar] [CrossRef] [Scilit]
- Kretowicz, M.; Johnson, R.J.; Ishimoto, T.; Nakagawa, T.; Manitius, J. The Impact of Fructose on Renal Function and Blood Pressure. Int. J. Nephrol. 2011, 2011, 315879. [Google Scholar] [CrossRef] [Scilit]
- Nakagawa, T.; Tuttle, K.R.; Short, R.A.; Johnson, R.J. Hypothesis: Fructose-Induced Hyperuricemia as a Causal Mechanism for the Epidemic of the Metabolic Syndrome. Nat. Clin. Pract. Nephrol. 2005, 1, 80–86. [Google Scholar] [CrossRef] [Scilit]
- Pokrywczynska, M.; Flisinski, M.; Jundzill, A.; Krzyzanowska, S.; Brymora, A.; Deptula, A.; Bodnar, M.; Kloskowski, T.; Stefanska, A.; Marszalek, A.; et al. Impact of Fructose Diet and Renal Failure on the Function of Pancreatic Islets. Pancreas 2014, 43, 801–808. [Google Scholar] [CrossRef] [Scilit]
- Johnson, R.J.; Perez-Pozo, S.E.; Sautin, Y.Y.; Manitius, J.; Sanchez-Lozada, L.G.; Feig, D.I.; Shafiu, M.; Segal, M.; Glassock, R.J.; Shimada, M.; et al. Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes? Endocr. Rev. 2009, 30, 96–116. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Johnson, R.J.; Segal, M.S.; Sautin, Y.; Nakagawa, T.; Feig, D.I.; Kang, D.-H.; Gersch, M.S.; Benner, S.; Sánchez-Lozada, L.G. Potential Role of Sugar (Fructose) in the Epidemic of Hypertension, Obesity and the Metabolic Syndrome, Diabetes, Kidney Disease, and Cardiovascular Disease. Am. J. Clin. Nutr. 2007, 86, 899–906. [Google Scholar] [CrossRef] [Scilit]
- Sánchez-Lozada, L.G.; Tapia, E.; Jiménez, A.; Bautista, P.; Cristóbal, M.; Nepomuceno, T.; Soto, V.; Avila-Casado, C.; Nakagawa, T.; Johnson, R.J.; et al. Fructose-Induced Metabolic Syndrome Is Associated with Glomerular Hypertension and Renal Microvascular Damage in Rats. Am. J. Physiol. Renal Physiol. 2007, 292, F423–F429. [Google Scholar] [CrossRef] [Scilit]
- Scales, C.D.; Smith, A.C.; Hanley, J.M.; Saigal, C.S. Urologic Diseases in America Project Prevalence of Kidney Stones in the United States. Eur. Urol. 2012, 62, 160–165. [Google Scholar] [CrossRef] [Scilit]
- Sas, D.J. An Update on the Changing Epidemiology and Metabolic Risk Factors in Pediatric Kidney Stone Disease. Clin. J. Am. Soc. Nephrol. CJASN 2011, 6, 2062–2068. [Google Scholar] [CrossRef] [Scilit]
- Taylor, E.N.; Curhan, G.C. Fructose Consumption and the Risk of Kidney Stones. Kidney Int. 2008, 73, 207–212. [Google Scholar] [CrossRef] [Scilit]
- Koh, E.T.; Reiser, S.; Fields, M. Dietary Fructose as Compared to Glucose and Starch Increases the Calcium Content of Kidney of Magnesium-Deficient Rats. J. Nutr. 1989, 119, 1173–1178. [Google Scholar] [CrossRef] [Scilit]
- Ng, H.-Y.; Lee, Y.-T.; Kuo, W.-H.; Huang, P.-C.; Lee, W.-C.; Lee, C.-T. Alterations of Renal Epithelial Glucose and Uric Acid Transporters in Fructose Induced Metabolic Syndrome. Kidney Blood Press. Res. 2018, 43, 1822–1831. [Google Scholar] [CrossRef] [Scilit]
- Nguyen, N.U.; Dumoulin, G.; Henriet, M.T.; Regnard, J. Increase in Urinary Calcium and Oxalate after Fructose Infusion. Horm. Metab. Res. Horm. Stoffwechselforsch. Horm. Metab. 1995, 27, 155–158. [Google Scholar] [CrossRef] [Scilit]
- Abate, N.; Chandalia, M.; Cabo-Chan, A.V.; Moe, O.W.; Sakhaee, K. The Metabolic Syndrome and Uric Acid Nephrolithiasis: Novel Features of Renal Manifestation of Insulin Resistance. Kidney Int. 2004, 65, 386–392. [Google Scholar] [CrossRef] [Scilit]
- Asselman, M.; Verkoelen, C.F. Fructose Intake as a Risk Factor for Kidney Stone Disease. Kidney Int. 2008, 73, 139–140. [Google Scholar] [CrossRef] [Scilit]
- Sakhaee, K.; Capolongo, G.; Maalouf, N.M.; Pasch, A.; Moe, O.W.; Poindexter, J.; Adams-Huet, B. Metabolic Syndrome and the Risk of Calcium Stones. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.—Eur. Ren. Assoc. 2012, 27, 3201–3209. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Siener, R. Nutrition and Kidney Stone Disease. Nutrients 2021, 13, 1917. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Khan, S.R.; Glenton, P.A. Calcium Oxalate Crystal Deposition in Kidneys of Hypercalciuric Mice with Disrupted Type IIa Sodium-Phosphate Cotransporter. Am. J. Physiol. Renal Physiol. 2008, 294, F1109–F1115. [Google Scholar] [CrossRef] [Scilit]
- Khan, S.R. Nephrocalcinosis in Animal Models with and without Stones. Urol. Res. 2010, 38, 429–438. [Google Scholar] [CrossRef] [Scilit]
- Oron-Herman, M.; Rosenthal, T.; Sela, B.-A. Hyperhomocysteinemia as a Component of Syndrome X. Metabolism 2003, 52, 1491–1495. [Google Scholar] [CrossRef] [Scilit]
- Hwang, S.-Y.; Woo, C.W.H.; Au-Yeung, K.K.W.; Siow, Y.L.; Zhu, T.Y.; Karmin, O. Homocysteine Stimulates Monocyte Chemoattractant Protein-1 Expression in the Kidney via Nuclear Factor-KappaB Activation. Am. J. Physiol. Renal Physiol. 2008, 294, F236–F244. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Cirillo, P.; Gersch, M.S.; Mu, W.; Scherer, P.M.; Kim, K.M.; Gesualdo, L.; Henderson, G.N.; Johnson, R.J.; Sautin, Y.Y. Ketohexokinase-Dependent Metabolism of Fructose Induces Proinflammatory Mediators in Proximal Tubular Cells. J. Am. Soc. Nephrol. JASN 2009, 20, 545–553. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kizhner, T.; Werman, M.J. Long-Term Fructose Intake: Biochemical Consequences and Altered Renal Histology in the Male Rat. Metabolism 2002, 51, 1538–1547. [Google Scholar] [CrossRef] [Scilit]
- Gersch, M.S.; Mu, W.; Cirillo, P.; Reungjui, S.; Zhang, L.; Roncal, C.; Sautin, Y.Y.; Johnson, R.J.; Nakagawa, T. Fructose, but Not Dextrose, Accelerates the Progression of Chronic Kidney Disease. Am. J. Physiol. Renal Physiol. 2007, 293, F1256–F1261. [Google Scholar] [CrossRef] [Scilit]
- Nakayama, T.; Kosugi, T.; Gersch, M.; Connor, T.; Sanchez-Lozada, L.G.; Lanaspa, M.A.; Roncal, C.; Perez-Pozo, S.E.; Johnson, R.J.; Nakagawa, T. Dietary Fructose Causes Tubulointerstitial Injury in the Normal Rat Kidney. Am. J. Physiol. Renal Physiol. 2010, 298, F712–F720. [Google Scholar] [CrossRef] [Scilit]
- Nakagawa, T.; Hu, H.; Zharikov, S.; Tuttle, K.R.; Short, R.A.; Glushakova, O.; Ouyang, X.; Feig, D.I.; Block, E.R.; Herrera-Acosta, J.; et al. A Causal Role for Uric Acid in Fructose-Induced Metabolic Syndrome. Am. J. Physiol. Renal Physiol. 2006, 290, F625–F631. [Google Scholar] [CrossRef] [Scilit]
- Spatola, L.; Ferraro, P.M.; Gambaro, G.; Badalamenti, S.; Dauriz, M. Metabolic Syndrome and Uric Acid Nephrolithiasis: Insulin Resistance in Focus. Metabolism 2018, 83, 225–233. [Google Scholar] [CrossRef] [Scilit]
- Hu, Q.-H.; Wang, C.; Li, J.-M.; Zhang, D.-M.; Kong, L.-D. Allopurinol, Rutin, and Quercetin Attenuate Hyperuricemia and Renal Dysfunction in Rats Induced by Fructose Intake: Renal Organic Ion Transporter Involvement. Am. J. Physiol. Renal Physiol. 2009, 297, F1080–F1091. [Google Scholar] [CrossRef] [Scilit]
- Milne, D.B.; Nielsen, F.H. The Interaction between Dietary Fructose and Magnesium Adversely Affects Macromineral Homeostasis in Men. J. Am. Coll. Nutr. 2000, 19, 31–37. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ng, R.C.; Rouse, D.; Suki, W.N. Calcium Transport in the Rabbit Superficial Proximal Convoluted Tubule. J. Clin. Investig. 1984, 74, 834–842. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Girardi, A.C.; Titan, S.M.; Malnic, G.; Rebouças, N.A. Chronic Effect of Parathyroid Hormone on NHE3 Expression in Rat Renal Proximal Tubules. Kidney Int. 2000, 58, 1623–1631. [Google Scholar] [CrossRef] [Scilit]
- Binswanger, U.; Helmle-Kolb, C.; Forgo, J.; Mrkic, B.; Murer, H. Rapid Stimulation of Na+/H+ Exchange by 1,25-Dihydroxyvitamin D3; Interaction with Parathyroid-Hormone-Dependent Inhibition. Pflugers Arch. 1993, 424, 391–397. [Google Scholar] [CrossRef] [Scilit]
- Lemann, J.; Piering, W.F.; Lennon, E.J. Possible Role of Carbohydrate-Induced Calciuria in Calcium Oxalate Kidney-Stone Formation. N. Engl. J. Med. 1969, 280, 232–237. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kohri, K.; Garside, J.; Blacklock, N.J. The Role of Magnesium in Calcium Oxalate Urolithiasis. Br. J. Urol. 1988, 61, 107–115. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Li, M.K.; Blacklock, N.J.; Garside, J. Effects of Magnesium on Calcium Oxalate Crystallization. J. Urol. 1985, 133, 123–125. [Google Scholar] [CrossRef] [Scilit]
- Fetner, C.D.; Barilla, D.E.; Townsend, J.; Pak, C.Y. Effects of Magnesium Oxide on the Crystallization of Calcium Salts in Urine in Patients with Recurrent Nephrolithiasis. J. Urol. 1978, 120, 399–401. [Google Scholar] [CrossRef] [Scilit]
- Bergstra, A.E.; Lemmens, A.G.; Beynen, A.C. Dietary Fructose vs. Glucose Stimulates Nephrocalcinogenesis in Female Rats. J. Nutr. 1993, 123, 1320–1327. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Manterys, A.; Filipiak-Florkiewicz, A.; Florkiewicz, A.; Franczyk-Zarow, M.; Kus, E.; Sady, M.; Kostogrys, R. Short-Term Feeding with High Fructose Diet Impairs Bone Mineralization in Growing Rats. Prog. Nutr. 2018, 20, 629–634. [Google Scholar] [CrossRef]
- Knox, F.G.; Osswald, H.; Marchand, G.R.; Spielman, W.S.; Haas, J.A.; Berndt, T.; Youngberg, S.P. Phosphate Transport along the Nephron. Am. J. Physiol.-Ren. Physiol. 1977, 233, F261–F268. [Google Scholar] [CrossRef] [Scilit]
- Douard, V.; Sabbagh, Y.; Lee, J.; Patel, C.; Kemp, F.W.; Bogden, J.D.; Lin, S.; Ferraris, R.P. Excessive Fructose Intake Causes 1,25-(OH)(2)D(3)-Dependent Inhibition of Intestinal and Renal Calcium Transport in Growing Rats. Am. J. Physiol. Endocrinol. Metab. 2013, 304, E1303–E1313. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Johnson, R.J.; Perez-Pozo, S.E.; Lillo, J.L.; Grases, F.; Schold, J.D.; Kuwabara, M.; Sato, Y.; Hernando, A.A.; Garcia, G.; Jensen, T.; et al. Fructose Increases Risk for Kidney Stones: Potential Role in Metabolic Syndrome and Heat Stress. BMC Nephrol. 2018, 19, 315. [Google Scholar] [CrossRef] [Scilit]
- Herlitz, L.C.; D’Agati, V.D.; Markowitz, G.S. Crystalline Nephropathies. Arch. Pathol. Lab. Med. 2012, 136, 713–720. [Google Scholar] [CrossRef] [Scilit]







| Determined Parameters | RD (I) | F10 (II) | F60 (III) | ANOVA | P |
|---|---|---|---|---|---|
| Food consumption [g/day] | 37.9 ± 2.5 | 27.2 ± 4.5 | 28.6 ± 2.4 | <0.001 | I vs. II I vs. III |
| Water consumption [mL/day] | 56 ± 9 | 90 ± 24.5 | 50 ± 14 | <0.01 | I vs. II II vs. III |
| Weight gain [gram] | 275 ± 23 | 275 ± 30 | 219 ± 37 | <0.01 | I vs. III II vs. III |
| Total energy value [kcal per day] | 99.6 ± 6.6 | 96.6 ± 10.3 | 102.8 ± 8.9 | NS | |
| Energy from fructose [kcal/day] | 3 ± 0.2 | 27.2 ± 5.5 | 61.7 ± 5.3 | <0.001 | I vs. II I vs. III II vs. III |
| Albumin [g/dL] | 3.3 ± 0.1 | 3.2 ± 0.2 | 3.1 ± 0.2 | NS | - |
| Fructose [mg/dL] | 0.59 ± 0.05 | 1.26 ± 0.7 | 1.04 ± 0.5 | NS | - |
| BUN [mg/dL] | 20.8 ± 1.4 | 18.1 ± 5.2 | 18.7 ± 2.6 | NS | - |
| HCS [µmol/L] | 4.5 ± 0.2 | 5.8 ± 1.4 | 6.4 ± 1.5 | < 0.05 | I vs. III |
| Creatinine [mg/dL] | 0.54 ± 0.04 | 0.59 ± 0.09 | 0.47 ± 0.04 | < 0.05 | II vs. III |
| Creatinine clearance [mL/min/100 g] | 0.47 ± 0.08 | 0.40 ± 0.08 | 0.44 ± 0.09 | NS | - |
| Erythropoietin [mIU/mL] | 0.65 ± 0.56 | 1.72 ± 2.01 | 1.33 ± 0.84 | NS | - |
| Uric Acid [mg/dL] | 1.76 ± 0.4 | 1.45 ± 0.3 | 1.56 ± 0.1 | NS | - |
| Insulin [ng/mL] | 3.87 ± 2.0 | 5.54 ± 2.4 | 5.31 ± 1.2 | NS | - |
| HOMA [AU] | 1.94 ± 0.95 | 3.13 ± 1.036 | 2.36 ± 0.81 | NS | - |
| Triglicerides [mg/dL] | 158 ± 34 | 180 ± 27 | 221 ± 83 | NS | - |
| Cholesterol [mg/dL] | 74 ± 11 | 60 ± 9 | 66 ± 9 | NS | - |
| PTH [pg/mL] | 225 ± 112 | 283 ± 136 | 492 ± 340 | NS | - |
| Vitamin 25(OH)D3 [ng/mL] | 52 ± 11 | 19 ± 17 | 31 ±44 | NS | - |
| FGF-23 [pg/mL] | 212 ± 66 | 379 ±324 | 216 ± 51 | NS | - |
| Calcium [mmol/L] | 2.52 ± 0.05 | 2.53 ± 0.11 | 2.44 ± 0.09 | NS | - |
| Phosphate [mmol/L] | 2.32 ± 0.1 | 2.39 ± 0.2 | 2.60 ± 0.2 | NS | - |
| CaxPi [mmol2/L2] | 5.85 ± 0.36 | 6.04 ± 0.49 | 6.34 ± 0.59 | NS | - |
| Magnesium [mmol/L] | 2.26 ± 0.1 | 2.54 ± 0.4 | 2.23 ± 0.3 | NS | - |
| Sodium [mmol/L] | 140.02 ± 1.68 | 139.34 ± 3.50 | 140.03 ± 2.54 | NS | - |
| Potassium [mmol/L] | 5.14 ± 0.95 | 5.42 ± 0.72 | 5.07 ± 0.48 | NS | - |
| Determined Parameters | RD (I) | F10 (II) | F60 (III) | ANOVA | P |
|---|---|---|---|---|---|
| Urine output [mL/day] | 26 ± 9.6 | 56 ± 27 | 25 ± 13 | < 0.001 | I vs. II II vs. III |
| Urine pH | 8.5 ± 0.57 | 8.2 ± 0.83 | 5.6 ± 0.51 | < 0.001 | I vs. III II vs. III |
| Urine specific gravity [g/L] | 1.0125 ± 0.003 | 1.014 ± 0.004 | 1.026 ± 0.004 | < 0.001 | I vs. III II vs. III |
| PCR [mg/mg Cr] | 1.0 ± 0.4 | 1.1 ± 0.5 | 0.8 ± 0.5 | NS | - |
| MCP-1/Cr [ng/mg Cr] | 3.5 ± 0.6 | 4.4 ± 4.0 | 11.2 ± 2.5 | < 0.01 | I vs. III II vs. III |
| NAG/Cr [U/g Cr] | 8.6 ± 5 | 15.1 ± 7.6 | 20.8 ± 5 | < 0.05 | I vs. III |
| uUAEx [mg/day] | 3.28 ± 0.51 | 2.58 ± 0.57 | 2.18 ± 0.66 | < 0.05 | I vs. III |
| UACl (mL/min) | 0.10 ± 0.04 | 0.13 ± 0.04 | 0.10 ± 0.03 | NS | - |
| UAFEx [%] | 4.4 ± 1.2 | 5.2 ± 1.6 | 4.1 ± 1.6 | NS | - |
| uNaEx [mg/day] | 33.3 ± 8.5 | 40.9 ± 10.8 | 166.8 ± 27.2 | < 0.001 | I vs. III II vs. III |
| NaCl [mL/min] | 0.007 ± 0.002 | 0.008 ± 0.002 | 0.031 ± 0.013 | < 0.001 | I vs. III II vs. III |
| NaFEx [%] | 0.24 ± 0.08 | 0.34 ± 0.06 | 1.16 ± 0.45 | < 0.001 | I vs. III II vs. III |
| uPiEx [mg/day] | 1.85 ± 1.61 | 4.42 ± 5.14 | 75.30 ± 21.95 | < 0.001 | I vs. III II vs. III |
| PiCl [mL/min] | 0.017 ± 0.015 | 0.044 ± 0.056 | 0.567 ± 0.284 | < 0.001 | I vs. III II vs. III |
| PiFEx [%] | 0.6 ± 0.6 | 1.7 ± 0.2 | 21 ± 5 | < 0.001 | I vs. III II vs. III |
| uCaEx [mg/day] | 2.02 ± 0.89 | 5.71 ± 3.05 | 3.08 ± 1.92 | < 0.05 | I vs. II |
| CaCl [mL/min] | 0.014 ± 0.006 | 0.038 ± 0.020 | 0.019 ± 0.014 | < 0.05 | I vs. II |
| CaFEx [%] | 0.45 ± 0.2 | 1.46 ± 0.7 | 0.75 ± 0.5 | < 0.05 | I vs. II |
| uMgEx [mg/day] | 5.2 ± 1.9 | 5.9 ± 2.1 | 3.9 ± 1.4 | NS | - |
| MgCl [mL/min] | 0.19 ± 0 | 0.17 ± 0.07 | 0.11 ± 0.3 | NS | - |
| MgFEx [%] | 5.4 ± 0 | 6.7 ± 2.5 | 4.4 ± 0.7 | NS | - |
| uKEx [mg/day] | 174.3 ± 19.9 | 152.1 ± 26.1 | 124.9 ± 45.3 | NS | - |
| KCl [mL/min] | 0.61 ± 0.1 | 0.51 ± 0.1 | 0.45 ± 0.17 | NS | - |
| KFEx [%] | 19.74 ± 2.15 | 19.92 ± 4.73 | 16.85 ± 5.46 | NS | - |
| Determined Parameters | RD (I) | F10 (II) | F60 (III) | ANOVA | P |
|---|---|---|---|---|---|
| Sodium intake from diet [mg/day] | 113.7 ± 7.6 | 81.6 ± 13.6 | 142.0 ± 12.4 | <0.001 | I vs. II I vs. III II vs. III |
| uNaEx/Na consumed in diet [%] | 29.2 ± 6.8 | 50.7 ± 12.7 | 117.0 ± 10.4 | <0.001 | I vs. II I vs. III II vs. III |
| Calcium intake from diet [mg/day] | 417 ± 28 | 299 ± 50 | 174 ± 15 | <0.001 | I vs. II I vs. III II vs. III |
| uCaEx/Ca consumed in diet [%] | 0.5 ± 0.2 | 1.9 ± 0.9 | 1.8 ± 1.1 | <0.05 | I vs. II I vs. III |
| Phosphate intake from diet [mg/day] | 227 ± 15 | 163 ± 27 | 156 ± 14 | <0.001 | I vs. II I vs. III |
| uPiEx/Pi consumed in diet [%] | 0.8 ± 0.7 | 3.0 ± 3.6 | 47.7 ± 11.1 | <0.001 | I vs. III II vs. III |
| Metabolic Characteristics | Rats without Kidney Deposits (N = 7) | Rats with Kidney Deposits (N = 4) | ANOVA |
|---|---|---|---|
| Insulin [ng/mL] | 4.60 ± 1.60 | 6.86 ± 0.83 | <0.05 |
| uCaEx [mg/day] | 2.02 ± 0.89 | 5.71 ± 3.05 | <0.01 |
| CaCl [mL/min] | 0.018 ± 0.011 | 0.047 ± 0.015 | <0.01 |
| CaFEx [%] | 0.73 ± 0.42 | 1.67 ± 0.58 | <0.05 |
| uMgEx [mg/day] | 3.93 ± 1.22 | 6.39 ± 2.16 | <0.05 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Flisiński, M.; Brymora, A.; Skoczylas-Makowska, N.; Stefańska, A.; Manitius, J. Fructose-Rich Diet Is a Risk Factor for Metabolic Syndrome, Proximal Tubule Injury and Urolithiasis in Rats. Int. J. Mol. Sci. 2022, 23, 203. https://doi.org/10.3390/ijms23010203
Flisiński M, Brymora A, Skoczylas-Makowska N, Stefańska A, Manitius J. Fructose-Rich Diet Is a Risk Factor for Metabolic Syndrome, Proximal Tubule Injury and Urolithiasis in Rats. International Journal of Molecular Sciences. 2022; 23(1):203. https://doi.org/10.3390/ijms23010203
Chicago/Turabian StyleFlisiński, Mariusz, Andrzej Brymora, Natalia Skoczylas-Makowska, Anna Stefańska, and Jacek Manitius. 2022. "Fructose-Rich Diet Is a Risk Factor for Metabolic Syndrome, Proximal Tubule Injury and Urolithiasis in Rats" International Journal of Molecular Sciences 23, no. 1: 203. https://doi.org/10.3390/ijms23010203
APA StyleFlisiński, M., Brymora, A., Skoczylas-Makowska, N., Stefańska, A., & Manitius, J. (2022). Fructose-Rich Diet Is a Risk Factor for Metabolic Syndrome, Proximal Tubule Injury and Urolithiasis in Rats. International Journal of Molecular Sciences, 23(1), 203. https://doi.org/10.3390/ijms23010203

